Autologous marrow transplantation after karyotypic conversion to normal in blastic phase of chronic myelocytic leukemia.
A patient with blastic transformation of Philadelphia chromosome-positive chronic myelocytic leukemia was treated with acridinyl anisidide, which resulted in conversion to a normal karyotype. At that time, bone marrow was harvested and cryopreserved. After relapse, the patient was treated with cyclophosphamide and fractionated total body irradiation followed by autologous marrow transplantation. Serial karyotypes and blood counts, determined up to 14 months after transplantation, remained normal.
D016026:Bone Marrow Transplantation; D002904:Chromosomes, Human, 21-22 and Y; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007621:Karyotyping; D007951:Leukemia, Myeloid / Q000235:genetics / Q000628:therapy*; D008875:Middle Aged; D014182:Transplantation, Autologous
D003520:Cyclophosphamide